(Q77369665)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750368%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

A pilot study comparing basiliximab and anti-thymocyte globulin as induction therapy in sensitized renal allograft recipients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750368%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

0 references

C Mariat

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750368%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

A Afiani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750368%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

E Alamartine

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750368%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

D Thibaudin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750368%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

J P de Filippis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750368%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

F Berthoux

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750368%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 November 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750368%20AND%20SRC:MED&resulttype=core&format=json

Transplantation Proceedings

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750368%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750368%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

7-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750368%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

3192-3193

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750368%20AND%20SRC:MED&resulttype=core&format=json

Advantage of antithymocyte globulin induction in sensitized kidney recipients: a randomized prospective study comparing induction with and without antithymocyte globulin

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902357-0

7 January 2021

Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902357-0

7 January 2021

Basiliximab significantly reduces acute rejection in renal transplant patients given triple therapy with azathioprine

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902357-0

7 January 2021

An economic and quality-of-life assessment of basiliximab vs antithymocyte globulin immunoprophylaxis in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902357-0

7 January 2021

The evaluation of the safety and tolerability of two formulations of cyclosporine: neoral and sandimmune. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902357-0

7 January 2021

Simulect induction significantly decreases CMV infection in kidney recipients compared to OKT3

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902357-0

7 January 2021

10.1016/S0041-1345(01)02357-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750368%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference